Healthcare Disputes & Investigations
High‑stakes matters demand defensible analysis
When Scrutiny Hits, Data Must Do More Than Exist
Healthcare organizations operate in environments shaped by complex regulations, evolving payment models, and deeply fragmented data systems. When disputes or investigations arise, those same systems are suddenly examined in granular detail by regulators, enforcement agencies, opposing experts, and courts.
Inconsistencies across claims, clinical, and financial data can raise questions about intent, accuracy, and governance. Unsupported assumptions or unclear methodologies can erode credibility, prolong disputes, or materially alter outcomes.
Healthcare organizations engage BRG in connection with some of the industry’s most complex and consequential matters, including:
- Government investigations and regulatory inquiries involving regulatory agencies including the Department of Justice (DOJ), Federal Trade Commission (FTC), Centers for Medicare and Medicaid Services (CMS), and state authorities
- Commercial disputes and healthcare litigation
- Antitrust and competition matters, including merger‑related reviews
- Allegations involving billing, coding, utilization, and risk adjustment practices
- Monitorships and independent oversight arrangements
- Transaction‑related disputes and post‑deal scrutiny
Our Services
- Pricing and Regulations
- Patent Infringement
- Product Liability
Related Services
- Clinical & Quality Transformation
- Healthcare Advisory
- Healthcare Corporate Compliance & Risk Management
- Healthcare Financial Consulting
- Healthcare Operational Excellence
- Healthcare Performance Improvement
- Healthcare Policy
- Healthcare Revenue Management
- Healthcare Strategic Advisory
- Healthcare Technology, AI & Digital Solutions
- Healthcare Transactions & Strategy
Related Industries
Related Healthcare Disputes & Investigations Insights
PublicationPreparing Your Company's Data for Trade Compliance Investigations
September 23, 2026
PublicationSite-of-Care Shift for Physician-Administered Drug Therapies: 2026 Update
January 20, 2026
PublicationThe Financial Impact to Medicare from the 340B Drug Pricing Program (October 2025)
October 2025







